Skip to main content

Advertisement

SpringerLink
Log in

Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by an uncontrolled hyper-inflammatory response. We assessed the transfusion requirements and predictors of 30-day mortality for adult HLH patients. We identified all adult patients with a diagnosis of HLH at a large academic hospital from October 2003 through February 2017. We extracted patients’ clinical and laboratory data, including transfusion requirements, from their medical records. One-hundred sixteen patients were identified. Their median age was 48 years (range 18–82); 72(62%) were male. Median duration of hospital stay was 19 days (range 1–89 days). At 30 days from admission, 81(70%) patients were alive. Death was attributed to sepsis in 21 patients, lymphoma in six, bleeding in four, GVHD in one, liver failure in one, metastatic solid tumor in one, and unknown in one. Transfusion requirements at 30 days from admission were as follows: RBC, 86% of patients, median 6 units (range 1–58); platelets, 74% of patients, median 6 units (1–67); plasma, 40% of patients, median 4 units (1–56). Renal failure (OR = 4.39; P = 0.008) and hypofibrinogenemia (OR = 4.07; P = 0.009) correlated with 30-day mortality. The transfusion requirements for adult HLH patients were high. Our study indicated that renal insufficiency and hypofibrinogenemia are predictors of early death in adult HLH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014;5:69–86.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.

    Article  PubMed  Google Scholar 

  3. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233–46.

    Article  CAS  PubMed  Google Scholar 

  4. Ho C, Yao X, Tian L, Li FY, Podoltsev N, Xu ML. Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol. 2014;141:62–71.

    Article  PubMed  Google Scholar 

  5. Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem M. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;51:402–4.

    Article  PubMed  Google Scholar 

  6. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol. 2010;22:561–6.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lykens JE, Terrell CE, Zoller EE, Risma K, Jordan MB. Perforin is a critical physiologic regulator of T-cell activation. Blood. 2011;118:618–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Naneh O, Avcin T, Bedina Zavec A. Perforin and human diseases. Subcell Biochem. 2014;80:221–39.

    Article  CAS  PubMed  Google Scholar 

  9. Freeman HR, Ramanan AV. Review of haemophagocytic lymphohistiocytosis. Arch Dis Child. 2011;96:688–93.

    Article  CAS  PubMed  Google Scholar 

  10. Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol. 2015;90:220–4.

    Article  CAS  PubMed  Google Scholar 

  11. Weaver LK, Behrens EM. Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol. 2014;26:562–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Milner JD, Orekov T, Ward JM, Cheng L, Torres-Velez F, Junttila I, et al. Sustained IL-4 exposure leads to a novel pathway for hemophagocytosis, inflammation, and tissue macrophage accumulation. Blood. 2010;116:2476–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Canna SW, Behrens EM. Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes. Pediatr Clin North Am. 2012;59:329–44.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand. 1991;80:428–35.

    Article  CAS  PubMed  Google Scholar 

  15. Hayden A, Park S, Giustini D, Lee AY, Chen LY. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30:411–20.

    Article  PubMed  Google Scholar 

  16. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009;221:278–85.

    Article  CAS  PubMed  Google Scholar 

  17. Raschke RA, Garcia-Orr R. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest. 2011;140:933–8.

    Article  PubMed  Google Scholar 

  18. Padhi S, Varghese RG, Ramdas A, Phansalkar MD, Sarangi R. Hemophagocytic lymphohistiocytosis: critical reappraisal of a potentially under-recognized condition. Front Med. 2013;7:492–8.

    Article  PubMed  Google Scholar 

  19. Migdady Y, Weiner H, Lau E, Martin BA, Jeng MR, Oak J. Transfusion dependence is common in adults with hemophagocytic lymphohistiocytosis (HLH) and is associated with EBV viremia. Blood. 2017;130(Suppl 1):3737.

    Google Scholar 

  20. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis. 2003;36:306–12.

    Article  PubMed  Google Scholar 

  21. Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–16.

    Article  PubMed  Google Scholar 

  22. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, et al, Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49:440–52.

    Article  PubMed  Google Scholar 

  23. Popovsky MA. Transfusion and the lung: circulatory overload and acute lung injury. Vox Sang. 2004;87:62–5.

    Article  PubMed  Google Scholar 

  24. Pandey S, Vyas GN. Adverse effects of plasma transfusion. Transfusion. 2012;52:65S–79S.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Ranucci M, Pazzaglia A, Bianchini C, Bozzetti G, Isgrò G. Body size, gender, and transfusions as determinants of outcome after coronary operations. Ann Thorac Surg. 2008;85:481–6.

    Article  PubMed  Google Scholar 

  26. Bilgin YM, van de Watering LM, Versteegh MI, van Oers MH, Vamvakas EC, Brand A. Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion. 2011;51:2603–10.

    Article  PubMed  Google Scholar 

  27. Camus M, Jensen DM, Kovacs TO, Jensen ME, Markovic D, Gornbein J. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: large ulcers do worse. Aliment Pharmacol Ther. 2016;43:1080–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cohen JA, Alan N, Seicean A, Weil RJ. Risk associated with perioperative red blood cell transfusion in cranial surgery. Neurosurg Rev. 2017;40:633–42.

    Article  PubMed  Google Scholar 

  29. Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc. 2014;89:484–92.

    Article  PubMed  Google Scholar 

  30. Arca M, Fardet L, Galicier L, Rivière S, Marzac C, Aumont C, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol. 2015;168:63–8.

    Article  PubMed  Google Scholar 

  31. Aulagnon F, Lapidus N, Canet E, Galicier L, Boutboul D, Peraldi MN, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis. 2015;65:851–9.

    Article  PubMed  Google Scholar 

  32. Li F, Yang Y, Jin F, Dehoedt C, Rao J, Zhou Y, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China. Orphanet J Rare Dis. 2015;10:20.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wang YR, Qiu YN, Bai Y, Wang XF. A retrospective analysis of 56 children with hemophagocytic lymphohistiocytosis. J Blood Med. 2016;7:227–31.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI, 48202, USA

    Zaher K. Otrock

  2. Department of Pathology and Immunology, Barnes-Jewish Hospital, Washington University, St Louis, MO, USA

    Brenda J. Grossman & Charles S. Eby

Authors
  1. Zaher K. Otrock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brenda J. Grossman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles S. Eby
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zaher K. Otrock.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Otrock, Z.K., Grossman, B.J. & Eby, C.S. Transfusion requirements and 30-day mortality predictors for adult hemophagocytic lymphohistiocytosis. Int J Hematol 108, 485–490 (2018). https://doi.org/10.1007/s12185-018-2504-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-018-2504-5

Keywords

Search

Navigation